SCHEMBL6529615

SCHEMBL6529615

COC(=O)[C@@H](CC(C)C)Nc1nc(CCc2ccncc2)nc(Oc2ccc(OC)cc2)n1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 5/20 0.39
TAS1R1 Q7RTX1 5/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP2C9 P11712 1/20 0.38
NPR3 P17342 1/20 0.38
CYP2C19 P33261 1/20 0.38
POLB P06746 2/20 0.37
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 1/20 0.36
ANPEP P15144 2/20 0.35
ELANE P08246 3/20 0.35
ITGB1 P05556 1/20 0.35
ITGA4 P13612 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6529614 1.00 TAS1R3 (0.39) TAS1R3TAS1R1ALDH1A1CYP2C9NPR3
SCHEMBL6529224 0.80 NPR3 (0.56) TAS1R3TAS1R1ALDH1A1CYP2C9NPR3
SCHEMBL6530303 0.78 VNN1 (0.44) TAS1R3TAS1R1ALDH1A1CYP2C9NPR3
SCHEMBL6529952 0.76 NPR3 (0.42) TAS1R3TAS1R1ALDH1A1CYP2C9NPR3
SCHEMBL6529959 0.76 NPR3 (0.42) TAS1R3TAS1R1ALDH1A1CYP2C9NPR3
SCHEMBL6528199 0.73 ANPEP (0.43) TAS1R3TAS1R1CYP2C9NPR3CYP2C19
SCHEMBL6528195 0.73 ANPEP (0.43) TAS1R3TAS1R1CYP2C9NPR3CYP2C19
SCHEMBL6513091 0.70 HPGD (0.46) ALDH1A1CYP2C9NPR3CYP2C19SMN1; SMN2
SCHEMBL6531904 0.70 HPGD (0.46) ALDH1A1CYP2C9NPR3CYP2C19SMN1; SMN2
SCHEMBL6512165 0.69 NPR3 (0.47) TAS1R3TAS1R1CYP2C9NPR3CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed